These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33973184)

  • 1. COVID-19 and Cardiovascular Diseases.
    Geraiely B; Samiei N; Sadeghipour P; Talasaz AH; Mortazavi SH; Sattarzadeh Badkoubeh R
    Adv Exp Med Biol; 2021; 1318():263-291. PubMed ID: 33973184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of acute cardiovascular events in patients with COVID-19.
    Liao CT; Chang WT; Yu WL; Toh HS
    Rev Cardiovasc Med; 2020 Dec; 21(4):577-581. PubMed ID: 33388002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.
    Gramegna M; Baldetti L; Beneduce A; Pannone L; Falasconi G; Calvo F; Pazzanese V; Sacchi S; Pagnesi M; Moroni F; Ajello S; Melisurgo G; Agricola E; Camici PG; Scandroglio AM; Landoni G; Ciceri F; Zangrillo A; Cappelletti AM
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009413. PubMed ID: 32791953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.
    Khalid N; Chen Y; Case BC; Shlofmitz E; Wermers JP; Rogers T; Ben-Dor I; Waksman R
    Cardiovasc Revasc Med; 2020 Aug; 21(8):946-949. PubMed ID: 32423791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review.
    Pepera G; Tribali MS; Batalik L; Petrov I; Papathanasiou J
    Rev Cardiovasc Med; 2022 Jan; 23(1):28. PubMed ID: 35092220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study.
    Pellegrini D; Kawakami R; Guagliumi G; Sakamoto A; Kawai K; Gianatti A; Nasr A; Kutys R; Guo L; Cornelissen A; Faggi L; Mori M; Sato Y; Pescetelli I; Brivio M; Romero M; Virmani R; Finn AV
    Circulation; 2021 Mar; 143(10):1031-1042. PubMed ID: 33480806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.
    Choudry FA; Hamshere SM; Rathod KS; Akhtar MM; Archbold RA; Guttmann OP; Woldman S; Jain AK; Knight CJ; Baumbach A; Mathur A; Jones DA
    J Am Coll Cardiol; 2020 Sep; 76(10):1168-1176. PubMed ID: 32679155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing Patients With ST-Elevation Myocardial Infarction at the Epicenter of the COVID-19 Pandemic.
    Elbaum L; Rashed E; Kamran M
    Curr Probl Cardiol; 2021 Mar; 46(3):100716. PubMed ID: 33081993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience.
    Rodríguez-Leor O; Cid-Álvarez B; Pérez de Prado A; Rossello X; Ojeda S; Serrador A; López-Palop R; Martín-Moreiras J; Rumoroso JR; Cequier Á; Ibáñez B; Cruz-González I; Romaguera R; Moreno R; ; Villa M; Ruíz-Salmerón R; Molano F; Sánchez C; Muñoz-García E; Íñigo L; Herrador J; Gómez-Menchero A; Gómez-Menchero A; Caballero J; Ojeda S; Cárdenas M; Gheorghe L; Oneto J; Morales F; Valencia F; Ruíz JR; Diarte JA; Avanzas P; Rondán J; Peral V; Pernasetti LV; Hernández J; Bosa F; Lorenzo PLM; Jiménez F; Hernández JMT; Jiménez-Mazuecos J; Lozano F; Moreu J; Novo E; Robles J; Moreiras JM; Fernández-Vázquez F; Amat-Santos IJ; Gómez-Hospital JA; García-Picart J; Blanco BGD; Regueiro A; Carrillo-Suárez X; Tizón H; Mohandes M; Casanova J; Agudelo-Montañez V; Muñoz JF; Franco J; Del Castillo R; Salinas P; Elizaga J; Sarnago F; Jiménez-Valero S; Rivero F; Oteo JF; Alegría-Barrero E; Sánchez-Recalde Á; Ruíz V; Pinar E; Pinar E; Planas A; Ledesma BL; Berenguer A; Fernández-Cisnal A; Aguar P; Pomar F; Jerez M; Torres F; García R; Frutos A; Nodar JMR; García K; Sáez R; Torres A; Tellería M; Sadaba M; Mínguez JRL; Merchán JCR; Portales J; Trillo R; Aldama G; Fernández S; Santás M; Pérez MPP
    Rev Esp Cardiol (Engl Ed); 2020 Dec; 73(12):994-1002. PubMed ID: 32917566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic.
    Correale M; Croella F; Leopizzi A; Mazzeo P; Tricarico L; Mallardi A; Fortunato M; Magnesa M; Ceci V; Puteo A; Iacoviello M; Di Biase M; Brunetti ND
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):341-351. PubMed ID: 34328581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should We Postpone Elective Cardiovascular Procedures and Percutaneous Coronary Interventions During the COVID-19 Pandemic?
    Keskin G; Khalil E; Uysal A
    Heart Surg Forum; 2021 Jan; 24(1):E022-E030. PubMed ID: 33635255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular system and COVID-19: perspectives from a developing country.
    Kunal S; Gupta K; Sharma SM; Pathak V; Mittal S; Tarke C
    Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32380802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
    Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
    Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 infection complicated by acute ST-elevation myocardial infarction.
    Fu T; Mamaliga G; Pierce JD; Gilkeson R; Gupta A
    Clin Imaging; 2021 Oct; 78():117-120. PubMed ID: 33774577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.
    Butala NM; Patel NK; Chhatwal J; Vahdat V; Pomerantsev EV; Albaghdadi M; Sakhuja R; Rosenzweig A; Elmariah S
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e010027. PubMed ID: 33167699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic : A review.
    Burger AL; Kaufmann CC; Jäger B; Pogran E; Ahmed A; Wojta J; Farhan S; Huber K
    Wien Klin Wochenschr; 2021 Dec; 133(23-24):1289-1297. PubMed ID: 34671829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China.
    Ranard LS; Parikh SA; Kirtane AJ
    J Am Coll Cardiol; 2020 Sep; 76(11):1325-1327. PubMed ID: 32807587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).
    Mahmud E; Dauerman HL; Welt FGP; Messenger JC; Rao SV; Grines C; Mattu A; Kirtane AJ; Jauhar R; Meraj P; Rokos IC; Rumsfeld JS; Henry TD
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):336-345. PubMed ID: 32311816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
    Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
    Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Çinier G; Hayıroğlu M; Pay L; Yumurtaş A; Tezen O; Parsova KE; Tekkesin I
    Turk Kardiyol Dern Ars; 2020 Oct; 48(7):640-645. PubMed ID: 33034585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.